The currently widely used modalities for the diagnosis of ovarian cancer include markers like carbohydrate antigen 125 (CA125), human epididymis protein 4 (HE4), and algorithms like Risk of Ovarian Malignancy Algorithm (ROMA) and Risk of Malignancy Index (RMI). This evidence concerns the gene WFDC2 and ovarian carcinoma.